INZY Market Cap History
Below is a table of the INZY market cap history going back to 7/24/2020:

Date INZY Market Cap

Also see: INZY Shares Outstanding History
and INZY YTD Return
INZY Historical Market Cap:
+192.79% CAGR
INZY Historical Market Cap: +192.79% CAGR

Mouse over chart for data details
Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization impacting the vasculature, soft tissue and skeleton. Co. is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Co.'s primary product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies. This pathway is central to the regulation of calcium deposition and is further associated with neointimal proliferation, or the overgrowth of smooth muscle cells inside blood vessels. We show 3 historical shares outstanding datapoints in our INZY shares outstanding history coverage, used to compute INZY market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing INZY market cap history over the course of time is important for investors interested in comparing INZY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of INZY versus a peer is one thing; comparing INZY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like INZY can fluctuate over the course of history. With this page we aim to empower investors researching INZY by allowing them to research the INZY market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for INZY:
INZY SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Inozyme Pharma (INZY) is categorized under the Miscellaneous sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

IPA Market Cap History
IPIC Market Cap History
IPOA Market Cap History
IPOB Market Cap History
IPOC Market Cap History
IPV Market Cap History
IQDF Market Cap History
IQDG Market Cap History
ISCF Market Cap History
ISEE Market Cap History
More Miscellaneous companies »


INZY Market Cap History | | Copyright © 2017 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.